Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes

Completed

Conditions studied: Angina, Unstable

In brief

In a randomized, controlled clinical trial, point-of care testing at the bedside using the cardiac biomarker troponin I in ED patients with possible ACS will be compared to traditional testing of this assay for myocardial necrosis obtained in the central laboratory. Our hypothesis: point-of-care testing for troponin I will decrease the time for disposition of patients with possible ACS in the emergency setting and decrease the time required for administering appropriate therapies for these patients.

Key facts

Study ID

NCT00222352

Run by

University of Cincinnati

People needed

2000

Starts

2004-12-01

Expected to finish

2007-03-01

Last updated by the study team

2018-02-05

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >21 years old
• Chest pain or other symptoms that lead to drawing cardiac bio-markers for possible ACS diagnosis

You may not qualify if…

• Presentation with chest pain in the presence of a tachydysrhythmia (ventricular tachycardia, supraventricular tachycardia, or rapid atrial fibrillation)
• Presentation with ECG diagnostic for STEMI

Where it is running

• Stanford University — Stanford, California, United States
• William Beaumont Hospital — Royal Oak, Michigan, United States
• The Jewish Hospital — Cincinnati, Ohio, United States
• The University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.